Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

OYST

Oyster Point Pharma Inc

Oyster Point Pharma is a clinical-stage biopharmaceutical company that aims to develop and commercialize first-in-class pharmaceutical therapies for ocular surface diseases. The company's lead cand...

Oyster Point Pharma Inc Annual Report 2020

Healthcare Biotechnology NASDAQ 11-50

ATRC

AtriCure

Medical device company AtriCure, Inc. has established a strong presence in the cardiac ablation market, selling its radio frequency products and ablation systems to medical centers around the world...

AtriCure Annual Report 2023

Healthcare Medical Instruments & Supplies NASDAQ 501-1000

EBO

EBOS Group Limited

EBOS Group Limited is a healthcare and animal care product distributor based in Australia and New Zealand. The company offers a wide range of products from healthcare logistics to pet nutrition, wi...

EBOS Group Limited Annual Report 2023

Healthcare ASX 1001-5000

ACW

Actinogen Medical

Actinogen Medical is a biotechnology company that is listed on ASX and specializes in developing innovative therapies for neurological diseases such as those associated with dysregulated brain cort...

Actinogen Medical Annual Report 2023

Healthcare Biotechnology ASX 1-10

DHR

Danaher

Washington-based Danaher Corporation has established itself as a globally recognized name in the market for professional, medical, industrial, and commercial products and services. The company oper...

Danaher Annual Report 2023

Healthcare Diagnostic Substances NYSE 10,000+

QRX

QRxPharma Limited

QRxPharma Limited is a pharmaceutical company that specializes in producing and marketing pain management and central nervous system disorder therapies. The company is in the clinical stage of deve...

QRxPharma Limited Annual Report 2017

Healthcare Medical Laboratories & Research ASX 1-10

CHMA

Chiasma, Inc.

Chiasma, a biopharmaceutical company, is dedicated to developing and commercializing oral therapies to improve the lives of patients suffering from rare and severe chronic diseases. By utilizing it...

Chiasma, Inc. Annual Report 2019

Healthcare Biotechnology NASDAQ 51-200

PIQ

Proteomics International

Proteomics International is a medical technology company that specializes in proteomics, the study of proteins. The company has over 16 years of experience providing analytical services on a fee-fo...

Proteomics International Annual Report 2023

Healthcare Biotechnology ASX 11-50

BHVN

Biohaven Pharmaceutical Company

New Haven, Connecticut-based clinical-stage biopharmaceutical company Biohaven Ltd. is devoted to identifying, developing, and bringing to market therapies that treat debilitating neurological and ...

Biohaven Pharmaceutical Company Annual Report 2023

Healthcare Biotechnology NYSE 501-1000

RMD

ResMed

ResMed Inc., a California-based healthcare company, has gained recognition for its innovative medical devices and cloud-based software applications that provide medical solutions for respiratory di...

ResMed Annual Report 2023

Healthcare Medical Appliances & Equipment NYSE 5001-10,000

EVG

Evgen Pharma plc

Eaton Vance Management has launched and managed a closed-ended fixed income mutual fund known as the Eaton Vance Short Duration Diversified Income Fund. Focusing on fixed income markets in the Unit...

Evgen Pharma plc Annual Report 2023

Healthcare Biotechnology LSE 1-10

NVS

Novartis AG

Novartis AG, a Swiss multinational pharmaceutical company, is making strides in the healthcare industry through their extensive research and development of innovative medicines. Their operations co...

Novartis AG Annual Report 2023

Healthcare Drug Manufacturers - Major NYSE 10,000+

PXS

Pyxis Tankers

Maroussi-based Pyxis Tankers Inc. is a maritime transportation company that specializes in the tanker sector in the United States. Its fleet serves as a vessel for refined petroleum products such a...

Pyxis Tankers Annual Report 2023

Healthcare Drug Manufacturers - Other LSE 1-10

BD1

Bard1

BARD1 Life Sciences Ltd is an Australian medical diagnostics company that specialises in developing innovative diagnostic technologies and products for healthcare professionals and patients. The co...

Bard1 Annual Report 2019

Healthcare ASX 11-50

IMM

ImmuPharma- Plc

ImmuPharma is a London-based biopharmaceutical company that specializes in peptide-based therapeutics for a range of therapy areas, including autoimmunity, metabolism, anti-infectives, and cancer. ...

ImmuPharma- Plc Annual Report 2023

Healthcare Biotechnology LSE 11-50